IHC analysis of clinical human BRAFV600E PTC and corresponding BRAFWT-PTC samples revealed that EGER is highly expressed in BRAF-mutant tumor tissue (Figs. 7C-E). The gene discussed is BRAF; the disease is neoplasm.